Psychotic Disorders - Malta | Statista Market Forecast

Revenue in the Psychotic Disorders market is projected to reach US$4.91m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 2.95%, resulting in a market volume of US$5.68m by 2029.
In global comparison, most revenue will be generated United States (US$2.26bn in 2024).
In relation to total population figures, per person revenues of US$696.80 are generated in 2024.

Psychotic disorders are severe mental health disorders that cause changes in a person's way of thinking and their perception. Patients often have trouble differentiating between what they perceive and reality. Different types of psychotic disorders include schizophrenia, bipolar disorder, substance-induced psychotic disorder, delusional disorder, and brief psychotic disorder. However, this market only represents the sales of antipsychotic drugs that are used to treat schizophrenia and bipolar disorder.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Otsuka Pharmaceutical, Lundbeck, AbbVie, Allergan plc, Recordati S.p.A., Gadeon Richter, Sumitomo Pharma, Johnson & Johnson / Janssen, Vanda Pharmaceuticals, Alkermes, Eli Lilly, AstraZeneca, and Intra-Cellular Therapies

Antipsychotic drugs: Aripiprazole (Abilify), Asenapine (Saphris), Cariprazine (Vraylar), Clozapine (Clozaril, Versacloz), lumateperone (Caplyta), Lurasidone (Latuda), Olanzapine (Zyprexa), Quetiapine (Seroquel), Risperidone (Risperdal), Risperidone (Aristada), Ziprasidone (Geodon), Brexpiprazole (Rexulti), Iloperidone (Fanapt), and Paliperidone (Invega)

Psychotherapy
Talk therapy
Herbal medicines
Digital health apps
Deep Brain Stimulation (DBS)

The Psychotic Disorders market in Malta is experiencing steady growth and development.

Customer preferences: Customers in Malta are increasingly seeking effective treatment options for psychotic disorders. They prioritize medications that are proven to be safe and have minimal side effects. Additionally, customers prefer treatments that can be easily accessed and are affordable. They value personalized care and support from healthcare professionals, as well as access to educational resources to better understand their condition and manage their symptoms.

Trends in the market: One of the key trends in the Psychotic Disorders market in Malta is the growing availability and use of atypical antipsychotic medications. These medications have gained popularity due to their ability to effectively manage symptoms of psychotic disorders while minimizing side effects compared to older generation antipsychotics. The market is witnessing an increasing number of atypical antipsychotic medications being introduced, providing customers with more options to choose from based on their individual needs and preferences.Another trend in the market is the adoption of integrated care models for the treatment of psychotic disorders. This approach involves collaboration between different healthcare professionals, including psychiatrists, psychologists, social workers, and primary care physicians, to provide comprehensive and coordinated care to patients. Integrated care models have been shown to improve patient outcomes and reduce healthcare costs by ensuring that patients receive the right care at the right time.

Local special circumstances: One of the special circumstances in Malta is its small population size. With a population of around 500,000, the market for Psychotic Disorders is relatively small compared to larger countries. This can have an impact on the availability and accessibility of specialized healthcare services and treatments. However, the small population size also allows for more personalized and tailored care, as healthcare professionals are able to develop closer relationships with their patients and provide individualized treatment plans.

Underlying macroeconomic factors: Malta has a strong healthcare system and invests significantly in healthcare infrastructure and services. The government provides universal healthcare coverage, ensuring that all residents have access to necessary healthcare services, including treatment for psychotic disorders. This commitment to healthcare contributes to the growth and development of the Psychotic Disorders market in Malta.Additionally, Malta has a stable and growing economy, which provides individuals with the financial means to seek appropriate treatment for psychotic disorders. The country's strong economic performance supports the affordability and accessibility of medications and healthcare services, driving the demand for treatments in the market.In conclusion, the Psychotic Disorders market in Malta is experiencing steady growth and development. Customers in Malta prioritize safe and effective treatments, personalized care, and accessible resources. The market is witnessing trends such as the increasing use of atypical antipsychotic medications and the adoption of integrated care models. Special circumstances in Malta, such as its small population size, contribute to personalized care, while underlying macroeconomic factors, including a strong healthcare system and a stable economy, support the growth of the market.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.